社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
京北风
IP属地:北京
+关注
帖子 · 21
帖子 · 21
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
京北风
京北风
·
2021-04-09
$海湾资源(GURE)$
持仓4000股,怎么不显示,无法操作呀
看
4,420
回复
1
点赞
点赞
编组 21备份 2
分享
举报
京北风
京北风
·
2020-06-05
这是过山车吗?跌停、涨停,再跌停,在涨停,。。。
看
2,576
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
京北风
京北风
·
2020-03-09
$Spherix Incorporated(SPEX)$ 咋了,美股全都停牌了
看
3,389
回复
1
点赞
点赞
编组 21备份 2
分享
举报
京北风
京北风
·
2019-07-18
$Co-diagnostics Inc.(CODX)$先做多,开盘逢高做空
看
2,927
回复
1
点赞
2
编组 21备份 2
分享
举报
京北风
京北风
·
2019-07-18
$Co-diagnostics Inc.(CODX)$ 新闻稿:Co-Diagnostics Inc CoPrimer提供对液体活检样本中癌症突变的高性能检测 Co-Diagnostics Inc CoPrimer提供液体活检样本中癌症突变的高性能检测 俄亥俄州盐湖城,2019年7月18日(环球通讯社)-Co-Diagnostics,Inc.纳斯达克股票代码:CODX)是一家分子诊断公司,拥有开发分子诊断测试的独特专利平台,该公司今天宣布了一项利用其专利CoPrimer(TM)技术检测癌症突变的研究结果,该研究可应用于液体活检和伴随诊断测试。
看
4,735
回复
1
点赞
2
编组 21备份 2
分享
举报
京北风
京北风
·
2019-07-18
$Safe-T Group Ltd.(SFET)$先最多,高位在空
看
2,260
回复
评论
点赞
1
编组 21备份 2
分享
举报
京北风
京北风
·
2019-06-03
$Genocea Biosciences, Inc.(GNCA)$ 盘前到10,能不能空它?
看
2,678
回复
3
点赞
点赞
编组 21备份 2
分享
举报
京北风
京北风
·
2019-05-31
$Ameri Holdings, Inc.(AMRH)$ 毛票,没什么利好消息。盘前量大于昨日,关注
看
2,310
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
京北风
京北风
·
2019-05-29
今天继续有利好
$Soliton Inc(SOLY)$ 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯
+148.17%
14.220
SOLITON INC (SOLY.US)
新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。
看
3,178
回复
1
点赞
1
编组 21备份 2
分享
举报
今天继续有利好
京北风
京北风
·
2019-05-29
$Soliton Inc(SOLY)$ 今天继续有利好 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯
+148.17%
14.220
SOLITON INC (SOLY.US)
新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。
看
2,574
回复
评论
点赞
1
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3478140728481399","uuid":"3478140728481399","gmtCreate":1515551867313,"gmtModify":1515551867313,"name":"京北风","pinyin":"jbfjingbeifeng","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":24,"tweetSize":21,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.04","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.13","exceedPercentage":"60.31%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.93%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"北京","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":348750559,"gmtCreate":1617966706971,"gmtModify":1617966706971,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GURE\">$海湾资源(GURE)$</a>持仓4000股,怎么不显示,无法操作呀","listText":"<a href=\"https://laohu8.com/S/GURE\">$海湾资源(GURE)$</a>持仓4000股,怎么不显示,无法操作呀","text":"$海湾资源(GURE)$持仓4000股,怎么不显示,无法操作呀","images":[{"img":"https://static.tigerbbs.com/ff45161b606547954fd2876432f718a6","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/348750559","isVote":1,"tweetType":1,"viewCount":4420,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":958719449,"gmtCreate":1591365437981,"gmtModify":1704195558630,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"这是过山车吗?跌停、涨停,再跌停,在涨停,。。。","listText":"这是过山车吗?跌停、涨停,再跌停,在涨停,。。。","text":"这是过山车吗?跌停、涨停,再跌停,在涨停,。。。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/958719449","isVote":1,"tweetType":1,"viewCount":2576,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":981217668,"gmtCreate":1583761156054,"gmtModify":1704350687354,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Spherix Incorporated(SPEX)$ 咋了,美股全都停牌了","listText":"$Spherix Incorporated(SPEX)$ 咋了,美股全都停牌了","text":"$Spherix Incorporated(SPEX)$ 咋了,美股全都停牌了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/981217668","isVote":1,"tweetType":1,"viewCount":3389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":999432023,"gmtCreate":1563449785962,"gmtModify":1704705470343,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Co-diagnostics Inc.(CODX)$先做多,开盘逢高做空","listText":"$Co-diagnostics Inc.(CODX)$先做多,开盘逢高做空","text":"$Co-diagnostics Inc.(CODX)$先做多,开盘逢高做空","images":[{"img":"https://static.tigerbbs.com/ebb3b6651e839cb360c74443aef2dc69"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/999432023","isVote":1,"tweetType":1,"viewCount":2927,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":999431035,"gmtCreate":1563448379627,"gmtModify":1704705466677,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Co-diagnostics Inc.(CODX)$ 新闻稿:Co-Diagnostics Inc CoPrimer提供对液体活检样本中癌症突变的高性能检测 Co-Diagnostics Inc CoPrimer提供液体活检样本中癌症突变的高性能检测 俄亥俄州盐湖城,2019年7月18日(环球通讯社)-Co-Diagnostics,Inc.纳斯达克股票代码:CODX)是一家分子诊断公司,拥有开发分子诊断测试的独特专利平台,该公司今天宣布了一项利用其专利CoPrimer(TM)技术检测癌症突变的研究结果,该研究可应用于液体活检和伴随诊断测试。","listText":"$Co-diagnostics Inc.(CODX)$ 新闻稿:Co-Diagnostics Inc CoPrimer提供对液体活检样本中癌症突变的高性能检测 Co-Diagnostics Inc CoPrimer提供液体活检样本中癌症突变的高性能检测 俄亥俄州盐湖城,2019年7月18日(环球通讯社)-Co-Diagnostics,Inc.纳斯达克股票代码:CODX)是一家分子诊断公司,拥有开发分子诊断测试的独特专利平台,该公司今天宣布了一项利用其专利CoPrimer(TM)技术检测癌症突变的研究结果,该研究可应用于液体活检和伴随诊断测试。","text":"$Co-diagnostics Inc.(CODX)$ 新闻稿:Co-Diagnostics Inc CoPrimer提供对液体活检样本中癌症突变的高性能检测 Co-Diagnostics Inc CoPrimer提供液体活检样本中癌症突变的高性能检测 俄亥俄州盐湖城,2019年7月18日(环球通讯社)-Co-Diagnostics,Inc.纳斯达克股票代码:CODX)是一家分子诊断公司,拥有开发分子诊断测试的独特专利平台,该公司今天宣布了一项利用其专利CoPrimer(TM)技术检测癌症突变的研究结果,该研究可应用于液体活检和伴随诊断测试。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/999431035","isVote":1,"tweetType":1,"viewCount":4735,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":999498730,"gmtCreate":1563443367720,"gmtModify":1704705456575,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Safe-T Group Ltd.(SFET)$先最多,高位在空","listText":"$Safe-T Group Ltd.(SFET)$先最多,高位在空","text":"$Safe-T Group Ltd.(SFET)$先最多,高位在空","images":[{"img":"https://static.tigerbbs.com/14e0898b30b721f21d10c17e189f69f8"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/999498730","isVote":1,"tweetType":1,"viewCount":2260,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":902143734,"gmtCreate":1559565610728,"gmtModify":1704698476201,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Genocea Biosciences, Inc.(GNCA)$ 盘前到10,能不能空它?","listText":"$Genocea Biosciences, Inc.(GNCA)$ 盘前到10,能不能空它?","text":"$Genocea Biosciences, Inc.(GNCA)$ 盘前到10,能不能空它?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/902143734","isVote":1,"tweetType":1,"viewCount":2678,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":902963026,"gmtCreate":1559305500065,"gmtModify":1704698177750,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Ameri Holdings, Inc.(AMRH)$ 毛票,没什么利好消息。盘前量大于昨日,关注","listText":"$Ameri Holdings, Inc.(AMRH)$ 毛票,没什么利好消息。盘前量大于昨日,关注","text":"$Ameri Holdings, Inc.(AMRH)$ 毛票,没什么利好消息。盘前量大于昨日,关注","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/902963026","isVote":1,"tweetType":1,"viewCount":2310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":906433947,"gmtCreate":1559136165189,"gmtModify":1704697741892,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"title":"今天继续有利好","htmlText":"$Soliton Inc(SOLY)$ 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯 <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">+148.17%</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">14.220</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">SOLITON INC (SOLY.US)</a> 新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。","listText":"$Soliton Inc(SOLY)$ 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯 <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">+148.17%</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">14.220</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">SOLITON INC (SOLY.US)</a> 新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。","text":"$Soliton Inc(SOLY)$ 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯 +148.17% 14.220 SOLITON INC (SOLY.US) 新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/906433947","isVote":1,"tweetType":1,"viewCount":3178,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":906439220,"gmtCreate":1559136035760,"gmtModify":1704697741548,"author":{"id":"3478140728481399","authorId":"3478140728481399","name":"京北风","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3478140728481399","authorIdStr":"3478140728481399"},"themes":[],"htmlText":"$Soliton Inc(SOLY)$ 今天继续有利好 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯 <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">+148.17%</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">14.220</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">SOLITON INC (SOLY.US)</a> 新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。","listText":"$Soliton Inc(SOLY)$ 今天继续有利好 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯 <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">+148.17%</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">14.220</a> <a href=\"https://r.tigerbbs.com/lgq2\" target=\"_blank\">SOLITON INC (SOLY.US)</a> 新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。","text":"$Soliton Inc(SOLY)$ 今天继续有利好 在积极的概念验证试验结果后,孤立地启动关键纤维素试验,纤维素严重度评分提高20%-47% 2019-05-29 20:01 道琼斯 +148.17% 14.220 SOLITON INC (SOLY.US) 新闻稿:在经过积极的概念验证试验结果后,孤立子将启动关键的纤维素试验,并使纤维素严重程度评分提高20-47% 在积极的概念验证试验结果后,孤立地启动关键的纤维素试验,使纤维素严重程度评分提高20-47% 概念验证试验显示,单次20分钟非侵入性手术后,纤维素的无挫伤、无肿胀和无停机时间显著减少;因此,有理由继续进行关键试验。 公共关系新闻社 HOUSTON, May 29, 2019 休斯敦,2019年5月29日/PRNewswire/-Soliton公司(纳斯达克市场代码:Soly)(“Soliton”或“公司”),这是一家医疗设备公司,拥有得克萨斯大学为MD Anderson癌症中心(“MD Anderson”)授权的新型专有平台技术,今天宣布,决定推进一个关键的试验后,从它的概念证明的临床试验(“POC试验”)的积极数据为减少脂肪团确认后,在脂肪团的关键试验。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/906439220","isVote":1,"tweetType":1,"viewCount":2574,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}